Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leiomyosarcoma × nilotinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 83 Leukemia, Myeloid, Chronic-Phase 23 Leukemia 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Gastrointestinal Stromal Tumors 14 Blast Crisis 7 Neoplasms 6 Neoplasm Metastasis 6 Philadelphia Chromosome 4 Myeloproliferative Disorders 4 Recurrence 3 Melanoma 3 Leukemia, Myeloid, Acute 3 Leukemia, Myeloid 3 Hematologic Diseases 3 Bronchiolitis Obliterans Syndrome 3 Bone Marrow Diseases 3 Synovitis, Pigmented Villonodular 2 Ovarian Neoplasms 2 Neoplasm, Residual 2 Leukemia, Myeloid, Accelerated Phase 2 Colorectal Neoplasms 2 Substance Withdrawal Syndrome 1 Sarcoma 1 Retroperitoneal liposarcoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Piebaldism 1 Peritoneal Neoplasms 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1

Interventions

Doxorubicin 22 Gemcitabine 15 Trabectedin 11 Ifosfamide 11 Radiotherapy 10 Docetaxel 10 Dacarbazine 8 pazopanib 6 Temozolomide 4 Specimen Handling 4 Nivolumab 4 Biopsy 4 Sunitinib 3 Sorafenib 3 Filgrastim 3 pembrolizumab 2 pegfilgrastim 2 liposomal doxorubicin 2 eribulin 2 cixutumumab 2 cemiplimab 2 brostallicin 2 belinostat 2 avelumab 2 X-Rays 2 Surgical Procedures, Operative 2 Radiotherapy, Conformal 2 Radiation Dose Hypofractionation 2 Radiation 2 PTC596 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02587169 2015-10-27

GEIS-27

Broto, Javier Martín, M.D.

Phase 1/2 Unknown

Retroperitoneal liposarcoma, Chondrosarcoma, Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡